What this means
This trial studied how the body moves and clears azelaprag after single and repeated doses. It has finished, but no results have been posted yet, so we cannot say what it found.
Plain-English summary written by an AI model from the registry listing.
- Status
- Completed
- Who can join
- Ages 60 and over
- Where
- 1 site
The science
- Registered title
- Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy Volunteers
- Trial ID
- NCT06141889 ↗
- Phase
- PHASE 1
- Study type
- interventional
- Conditions
- Healthy Volunteer Study
- What is tested
- Azelaprag
- Sponsor
- BioAge Labs, Inc.
- Ages
- 60 Years to no maximum
- Dates
- First posted Nov 21, 2023 · updated Feb 23, 2024
Registry summary
This study is a single-dose, open-label, randomized crossover and multiple-dose, open-label study to evaluate the PK of azelaprag in older adult healthy volunteers.
Sites (1)
- New Zealand Clinical Research, Auckland, New Zealand